Elevated Soluble Vascular Cell Adhesion Molecule-1 Is Associated With Cerebrovascular Resistance and Cognitive Function

Overview

Journal J Gerontol A Biol Sci Med Sci

Specialty Geriatrics

Date 2016 Jun 19

PMID 27317684

Citations 18

Authors

Achille E Tchalla

Gregory A Wellenius

Farzaneh A Sorond

Margaret Gagnon

Ikechukwu Iloputaife

Thomas G Travison

Thierry Dantoine

Lewis A Lipsitz

Affiliations

Soon will be listed here.

Abstract

Background: Elevated plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) is a presumed marker of endothelial dysfunction, both in the brain and systemic circulation. Impairments in memory and cognition have been associated with cardiovascular diseases, but little is known about their relationships to abnormal cerebral endothelial function.

Methods: We studied the cross-sectional association between sVCAM-1 and markers of cerebrovascular hemodynamics and cognitive function in 680 community-dwelling participants in the MOBILIZE Boston Study, aged 65 years and older. Cognitive function was assessed using the Hopkins Verbal Learning Memory Test and Trail Making Tests (TMTs) A and B. Global cognitive impairment was defined as Mini-Mental State Examination (MMSE) score less than 24. sVCAM-1 was measured by ELISA assay. Beat-to-beat blood flow velocity (BFV) and cerebrovascular resistance (CVR = mean arterial pressure / BFV) in the middle cerebral artery were assessed at rest by transcranial Doppler ultrasound.

Results: sVCAM-1 concentrations were higher among participants with an MMSE score <24 versus ≥24 (1,201±417 vs 1,122±494ng/mL). In regression models adjusted for sociodemographic characteristics and health conditions, increasing levels of sVCAM-1 were linearly associated with higher resting CVR (p = .006) and lower performance on the Hopkins Verbal Learning Memory (immediate recall and delayed recall) and adjusted TMT B tests (p < .05). Higher levels of sVCAM-1 were also associated with global cognitive impairment on the MMSE (odds ratio = 3.9; 95% confidence interval: 1.4-10.9; p = .011).

Conclusions: In this cohort of elderly participants, we observed a cross-sectional association between elevated sVCAM-1 levels and both cognitive impairment and increased cerebrovascular resistance. Longitudinal studies are needed to determine whether elevated sVCAM-1 is a cause or consequence of cerebrovascular damage.

Citing Articles

Inflammation biomarkers and neurobehavioral performance in rural adolescents.

Amdemicael B, Yang K, Chronister B, Mackey C, Tu X, Gahagan S Brain Behav Immun Health. 2024; 43:100912.

PMID: 39686922 PMC: 11648784. DOI: 10.1016/j.bbih.2024.100912.

Biomarkers of endothelial dysfunction and cognition: A two-step IPD meta-analysis.

Beran M, Jansen W, Oomens J, Moonen J, Slagboom P, Huisman M Alzheimers Dement. 2024; 20(12):8402-8411.

PMID: 39428719 PMC: 11667552. DOI: 10.1002/alz.14272.

Profiling expressing features of surface proteins on single-exosome in first-episode Schizophrenia patients: a preliminary study.

Zhang S, Liao A, Wang Y, Liu Q, Ouyang L, Peng H Schizophrenia (Heidelb). 2024; 10(1):84.

PMID: 39349515 PMC: 11443124. DOI: 10.1038/s41537-024-00510-z.

Increased Expression of VCAM1 on Brain Endothelial Cells Drives Blood-Brain Barrier Impairment Following Chronic Cerebral Hypoperfusion.

Zhang H, Shang J, Li W, Gao D, Zhang J ACS Chem Neurosci. 2024; 15(10):2028-2041.

PMID: 38710594 PMC: 11099957. DOI: 10.1021/acschemneuro.4c00039.

Blood-to-brain communication in aging and rejuvenation.

Bieri G, Schroer A, Villeda S Nat Neurosci. 2023; 26(3):379-393.

PMID: 36646876 DOI: 10.1038/s41593-022-01238-8.

References

Meigs J, Hu F, Rifai N, Manson J . Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA. 2004; 291(16):1978-86. DOI: 10.1001/jama.291.16.1978. View

Gorina Y, Hoyert D, Lentzner H, Goulding M . Trends in causes of death among older persons in the United States. Aging Trends. 2009; (6):1-12. View

Sierra C, Domenech M, Camafort M, Coca A . Hypertension and mild cognitive impairment. Curr Hypertens Rep. 2012; 14(6):548-55. DOI: 10.1007/s11906-012-0315-2. View

Li Y, Teng J, Tsai W, Tsai L, Lin L, Chen J . Elevation of soluble adhesion molecules is associated with the severity of myocardial damage in acute myocardial infarction. Am J Cardiol. 1997; 80(9):1218-21. DOI: 10.1016/s0002-9149(97)00644-9. View

Barberger-Gateau P, Dartigues J, Letenneur L . Four Instrumental Activities of Daily Living Score as a predictor of one-year incident dementia. Age Ageing. 1993; 22(6):457-63. DOI: 10.1093/ageing/22.6.457. View

Skoog I, Gustafson D . Update on hypertension and Alzheimer's disease. Neurol Res. 2006; 28(6):605-11. DOI: 10.1179/016164106X130506. View

Glisky E, Kong L . Do young and older adults rely on different processes in source memory tasks? A neuropsychological study. J Exp Psychol Learn Mem Cogn. 2008; 34(4):809-22. PMC: 2504728. DOI: 10.1037/0278-7393.34.4.809. View

Chen B, Kozberg M, Bouchard M, Shaik M, Hillman E . A critical role for the vascular endothelium in functional neurovascular coupling in the brain. J Am Heart Assoc. 2014; 3(3):e000787. PMC: 4309064. DOI: 10.1161/JAHA.114.000787. View

Kelley B, Petersen R . Alzheimer's disease and mild cognitive impairment. Neurol Clin. 2007; 25(3):577-609, v. PMC: 2682228. DOI: 10.1016/j.ncl.2007.03.008. View

10.

Sorond F, Serrador J, Jones R, Shaffer M, Lipsitz L . The sit-to-stand technique for the measurement of dynamic cerebral autoregulation. Ultrasound Med Biol. 2008; 35(1):21-9. PMC: 2680703. DOI: 10.1016/j.ultrasmedbio.2008.08.001. View

11.

Hajjar I, Quach L, Yang F, Chaves P, Newman A, Mukamal K . Hypertension, white matter hyperintensities, and concurrent impairments in mobility, cognition, and mood: the Cardiovascular Health Study. Circulation. 2011; 123(8):858-65. PMC: 3081662. DOI: 10.1161/CIRCULATIONAHA.110.978114. View

12.

Wellenius G, Boyle L, Coull B, Milberg W, Gryparis A, Schwartz J . Residential proximity to nearest major roadway and cognitive function in community-dwelling seniors: results from the MOBILIZE Boston Study. J Am Geriatr Soc. 2012; 60(11):2075-80. PMC: 3498530. DOI: 10.1111/j.1532-5415.2012.04195.x. View

13.

Katz S, Ford A, Moskowitz R, Jackson B, JAFFE M . STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION. JAMA. 1963; 185:914-9. DOI: 10.1001/jama.1963.03060120024016. View

14.

Washburn R, Smith K, Jette A, Janney C . The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol. 1993; 46(2):153-62. DOI: 10.1016/0895-4356(93)90053-4. View

15.

Goveas J, Rapp S, Hogan P, Driscoll I, Tindle H, Smith J . Predictors of Optimal Cognitive Aging in 80+ Women: The Women's Health Initiative Memory Study. J Gerontol A Biol Sci Med Sci. 2016; 71 Suppl 1:S62-71. PMC: 4759985. DOI: 10.1093/gerona/glv055. View

16.

Muller W, Weigl S, Deng X, Phillips D . PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med. 1993; 178(2):449-60. PMC: 2191108. DOI: 10.1084/jem.178.2.449. View

17.

Eggermont L, Milberg W, Lipsitz L, Scherder E, Leveille S . Physical activity and executive function in aging: the MOBILIZE Boston Study. J Am Geriatr Soc. 2009; 57(10):1750-6. PMC: 3286835. DOI: 10.1111/j.1532-5415.2009.02441.x. View

18.

Escobar J, Burnam A, Karno M, Forsythe A, Landsverk J, Golding J . Use of the Mini-Mental State Examination (MMSE) in a community population of mixed ethnicity. Cultural and linguistic artifacts. J Nerv Ment Dis. 1986; 174(10):607-14. DOI: 10.1097/00005053-198610000-00005. View

19.

Shapiro A, Benedict R, Schretlen D, Brandt J . Construct and concurrent validity of the Hopkins Verbal Learning Test-revised. Clin Neuropsychol. 2000; 13(3):348-58. DOI: 10.1076/clin.13.3.348.1749. View

20.

Novak V, Zhao P, Manor B, Sejdic E, Alsop D, Abduljalil A . Adhesion molecules, altered vasoreactivity, and brain atrophy in type 2 diabetes. Diabetes Care. 2011; 34(11):2438-41. PMC: 3198286. DOI: 10.2337/dc11-0969. View